One Talk at a Time: Race for Behavioral Symptoms

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of North Carolina Greensboro, Greensboro, NC
Behavioral Symptoms+6 More
One Talk at a Time: Race - Other
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing an online video intervention to help parents talk to their kids about race. The goal is to see if it increases motivation and skills in having these conversations, and if it leads to better mental and academic outcomes for kids. One Talk at a Time: Race is a treatment for behavioral symptoms that has previously been approved by the FDA for a different condition. The treatment can be done online. No patients in this trial will receive a placebo.

Eligible Conditions

  • Behavioral Symptoms
  • Ethnic-racial Socialization
  • Mental Depression
  • Anxiety Disorders
  • Ethnic-Racial Socialization

Treatment Effectiveness

Study Objectives

4 Primary · 7 Secondary · Reporting Duration: Baseline, 3-month after intervention, 6-months after intervention, and 12-months after intervention

Baseline, 3-month after intervention, 6-months after intervention, and 12-months after intervention
Coping with Discrimination (Youth-reported) Youth Coping with Discrimination
Cultural Socialization Frequency (Parent and youth report)
Cultural Socialization Quality
Parental Confidence (Parent-reported)
Parental Motivation (Parent-reported)
Parental Skill (Parent-reported)
Preparation for Bias Frequency (Parent and youth report)
Preparation for Bias Quality
Youth Academic Motivation (Youth and parent report)
Youth Anxiety symptoms (Youth and parent report)
Youth Behavioral Symptoms (Youth and parent report)
Youth Coping Efficacy (Youth-report)
Youth Depressive symptoms (Youth and parent report)
Youth Racial-Ethnic Exploration (Youth-report)
Youth Racial-Ethnic Identity (Youth-report)
Youth Self-Esteem (Youth and parent report)

Trial Safety

Trial Design

2 Treatment Groups

Parent-Child Communication
1 of 2
OTAAT
1 of 2
Active Control
Experimental Treatment

312 Total Participants · 2 Treatment Groups

Primary Treatment: One Talk at a Time: Race · No Placebo Group · N/A

OTAAT
Other
Experimental Group · 1 Intervention: One Talk at a Time: Race · Intervention Types: Other
Parent-Child Communication
Other
ActiveComparator Group · 1 Intervention: One Talk at a Time: General · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 3-month after intervention, 6-months after intervention, and 12-months after intervention
Closest Location: University of North Carolina Greensboro · Greensboro, NC
N/AFirst Recorded Clinical Trial
1 TrialsResearching Behavioral Symptoms
0 CompletedClinical Trials

Who is running the clinical trial?

University of North Carolina, GreensboroLead Sponsor
26 Previous Clinical Trials
15,827 Total Patients Enrolled
Stephanie Coard, PhDPrincipal InvestigatorUniversity of North Carolina, Greensboro
Gabriela Livas Stein, PhDPrincipal InvestigatorUniversity of North Carolina, Greensboro
Laura Gonzalez, PhDPrincipal InvestigatorUniversity of North Carolina, Greensboro
Lisa Kiang, PhDPrincipal InvestigatorWake Forest University

Eligibility Criteria

Age Any Age · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a child between the ages of 11 and 13.
You are of East Asian, African American, Latinx (Central American) background.
You are from a pan-ethnic group.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.